Nifedipine: here's the fair price
This is what US pharmacies pay, on average, for nifedipine. Use it to spot a fair cash price, and feel good about asking for one.
Nifedipine Er 30 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Nifedipine Er 30 Mg Tablet. Pharmacies pay about $3.92 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| NIFEDIPINE ER 30 MG TABLETGeneric | $0.13 per tablet or capsule | $3.92 | 10/21/2026 |
| NIFEDIPINE ER 60 MG TABLETGeneric | $0.17 per tablet or capsule | $5.04 | 10/21/2026 |
| NIFEDIPINE ER 90 MG TABLETGeneric | $0.27 per tablet or capsule | $7.98 | 10/21/2026 |
| NIFEDIPINE 10 MG CAPSULEGeneric | $0.27 per tablet or capsule | $8.17 | 10/21/2026 |
| NIFEDIPINE 20 MG CAPSULEGeneric | $0.68 per tablet or capsule | $20.31 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
INDICATIONS & USAGE I. Vasospastic Angina Nifedipine extended-release tablets are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. In those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. Nifedipine extended-release tablets may also be used where the clinical presentation suggests a possible vasospastic...
Common side effects (FDA label)
ADVERSE EXPERIENCES Over 1000 patients from both controlled and open trials with nifedipine extended-release tablets in hypertension and angina were included in the evaluation of adverse experiences. All side effects reported during nifedipine extended-release tablets therapy were tabulated independent of their causal relation to medication. The most common side effect reported with nifedipine extended-release tablets was edema which was dose related and ranged in frequency from approximately 10% to about 30% at the highest dose studied (180 mg). Other common adverse experiences reported in...
Warnings (from the label)
WARNINGS Excessive Hypotension Although in most angina patients the hypotensive effect of nifedipine is modest and well tolerated, occasional patients have had excessive and poorly tolerated hypotension. These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment, and may be more likely in patients on concomitant beta blockers. Severe hypotension and/or increased fluid volume requirements have been reported in patients receiving nifedipine together with a beta-blocking agent who underwent coronary artery bypass surgery using high dose fentanyl anesthesia. The interaction with high dose fentanyl appears to be due to the combination of...
Source: FDA drug label via openFDA, label effective 2019-06-06. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.